معرفی
Björn Nilsson is a Professor and Research Team Manager at the Division of Hematology and Clinical Immunology at Lund University. He is a Principal Investigator at the Lund University Cancer Centre (LUCC), StemTherapy, and a Researcher in EpiHealth. His work bridges clinical, computational, and experimental expertise, with 16 team members focusing on genetic variation in blood cell formation and cancer risk.
Research Keywords: Genetic variation, hematology, bioinformatics, immunology, cancer genomics, stem cell biology
Scientific Contributions: His group has published in Nature Genetics, Nature Communications, and Blood, with clinically implemented discoveries.
- Genome-wide association studies for blood disorders
- Identification of key genes in immunoglobulin regulation
- Multi-omics analysis of multiple myeloma susceptibility
Projects:
- Genetic predisposition for multiple myeloma (2011–present)
- Genetic regulators of blood cell formation (2018–2023)
- Childhood leukemia genetic mechanisms (2025–2026)
- Sex differences in immunity (2024–present)
- Blood cancer risk and stem cell activity (2021–2029)
Network: Active collaborations in 5 countries, cited 144+ times, with 209 Mendeley readers on GWAS studies.
